NEW YORK, Oct. 11, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Iris Energy Limited (“Iris Energy” or the “Company”) (NASDAQ: IREN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to […]
Tag: LLP
Contact Levi & Korsinsky by October 15, 2024 Deadline to Join Class Action Against Sprinklr, Inc.(CXM)
NEW YORK, Oct. 11, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Sprinklr, Inc. (“Sprinklr” or the “Company”) (NYSE: CXM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses […]
Faruqi & Faruqi Reminds Lululemon Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 6, 2024
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In iLearningEngines To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in iLearningEngines […]
Faruqi & Faruqi Reminds Sprinklr Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Sprinklr To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Sprinklr […]
The Positive Topline Results From Phase III Study of UCB/Biogen’s Dapirolizumab Pegol Brings a Ray of Hope in Systemic Lupus Erythematosus Therapeutic Space
UCB and Biogen reported encouraging topline findings from the Phase III PHOENYCS GO trial, which assessed dapirolizumab pegol, a novel Fc-free anti-CD40L drug candidate, in individuals with moderate-to-severe SLE. The promising outcomes with dapirolizumab pegol […]